Myocardial Changes in Pediatric Guillain-Barré Syndrome
1 other identifier
observational
72
0 countries
N/A
Brief Summary
This prospective cohort study aims to identify and characterize cardiac changes including electrocardiographic, echocardiographic, and biochemical abnormalities in pediatric patients with Guillain-Barré syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedStudy Start
First participant enrolled
September 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 26, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 25, 2028
September 25, 2026
September 1, 2026
1 year
September 21, 2026
September 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of cardiac abnormalities
Proportion of patients with any cardiac abnormality detected by electrocardiography, echocardiography, or elevated cardiac biomarkers (troponin I or CK-MB).
Baseline
Secondary Outcomes (5)
Prevalence of electrocardiographic abnormalities
Baseline
Mean left ventricular ejection fraction (LVEF)
Baseline
Prevalence of elevated cardiac troponin I
Baseline
Prevalence of cardiac abnormalities at follow-up
At 3 months
Mean left ventricular ejection fraction at follow-up
At 3 months
Study Arms (1)
Single cohort: Pediatric patients with Guillain-Barré syndrome
Pediatric patients with confirmed Guillain-Barré syndrome who will undergo cardiac evaluation at admission and at 3-month follow-up.
Eligibility Criteria
Pediatric patients aged 1 month to 18 years with confirmed Guillain-Barré syndrome admitted to Assiut University Children's Hospital.
You may qualify if:
- Age 1 month to 18 years
- Confirmed diagnosis of Guillain-Barré syndrome
- Onset of neurological symptoms within 2 weeks prior to hospital presentation
- No pre-existing cardiac disease
- Written informed consent from parents or legal guardians
You may not qualify if:
- Pre-existing congenital or acquired heart disease
- Pre-existing neuromuscular disorders or hereditary peripheral neuropathies
- Incomplete cardiac workup (inability to perform ECG, echocardiography, and cardiac biomarker assessment)
- Loss to follow-up before hospital discharge
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Faisal A Ahmed, prof
Pediatrics Department, Assiut University Hospitals
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Physician, Department of Pediatrics
Study Record Dates
First Submitted
September 21, 2026
First Posted
September 25, 2026
Study Start
September 26, 2026
Primary Completion (Estimated)
September 26, 2027
Study Completion (Estimated)
January 25, 2028
Last Updated
September 25, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share